Chronic central administration of ghrelin reverses the effects of leptin

被引:30
作者
Kim, MS
Namkoong, C
Kim, HS
Jang, PG
Pak, YMK
Katakami, H
Park, JY
Lee, KU [1 ]
机构
[1] Univ Ulsan, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seoul 138736, South Korea
[2] Univ Ulsan, Coll Med, Asan Inst Life Sci, Seoul 138736, South Korea
[3] Miyazaki Med Coll, Dept Internal Med, Kiyotake, Miyazaki, Japan
关键词
ghrelin; leptin; intracerebroventricular; food intake; adiposity; metabolic effect;
D O I
10.1038/sj.ijo.0802647
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE: To determine whether chronic central administration of ghrelin can block the effects of leptin on food intake, adiposity, and plasma concentrations of metabolic parameters and hormones. DESIGN: Intracerebroventricular (ICV) infusions of leptin (5 mg/day) for 7 days, with or without ghrelin (1.2 mug/day), in rats. Rats administered leptin plus ghrelin were divided into ad lib-fed and food-restricted groups. MEASUREMENT: Body weight and food intake were monitored daily. Following killing on day 8, epididymal fat weight and fasting plasma concentrations of glucose, insulin, leptin, ghrelin, IGF-1, and adiponectin were determined. RESULTS: ICV infusion of leptin decreased food intake by 39% and fat weight by 41%. Leptin decreased plasma concentrations of glucose, insulin, and leptin and increased plasma ghrelin levels. Central coadministration of ghrelin blocked the effects of leptin. Most of the effects of ghrelin were diminished by food restriction but ghrelin effect on adiposity and plasma insulin concentrations remained in food-restricted rats. CONCLUSION: Chronic central administration of ghrelin reversed the effects of leptin, primarily by altering food intake, but ghrelin may have regulatory effects on adiposity and plasma insulin levels independent of feeding effect.
引用
收藏
页码:1264 / 1271
页数:8
相关论文
共 36 条
[1]   Leptin [J].
Ahima, RS ;
Flier, JS .
ANNUAL REVIEW OF PHYSIOLOGY, 2000, 62 :413-437
[2]   Acute intravenous leptin infusion increases glucose turnover but not skeletal muscle glucose uptake in ob/ob mice [J].
Burcelin, R ;
Kamohara, S ;
Li, J ;
Tannenbaum, GS ;
Charron, MJ ;
Friedman, JM .
DIABETES, 1999, 48 (06) :1264-1269
[3]   Regulation of in vivo growth hormone secretion by leptin. [J].
Carro, E ;
Senaris, R ;
Considine, RV ;
Casanueva, FF ;
Dieguez, C .
ENDOCRINOLOGY, 1997, 138 (05) :2203-2206
[4]   Proopiomelanocortin neurons are direct targets for leptin in the hypothalamus [J].
Cheung, CC ;
Clifton, DK ;
Steiner, RA .
ENDOCRINOLOGY, 1997, 138 (10) :4489-4492
[5]   A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans [J].
Cummings, DE ;
Purnell, JQ ;
Frayo, RS ;
Schmidova, K ;
Wisse, BE ;
Weigle, DS .
DIABETES, 2001, 50 (08) :1714-1719
[6]   The weight-reducing effect of an intracerebroventricular bolus injection of leptin in genetically Obese falfa rats - Reduced sensitivity compared with lean animals [J].
Cusin, I ;
RohnerJeanrenaud, F ;
StrickerKrongrad, A ;
Jeanrenaud, B .
DIABETES, 1996, 45 (10) :1446-1451
[7]   Ghrelin is present in pancreatic α-cells of humans and rats and stimulates insulin secretion [J].
Date, Y ;
Nakazato, M ;
Hashiguchi, S ;
Dezaki, K ;
Mondal, MS ;
Hosoda, H ;
Kojima, M ;
Kangawa, K ;
Arima, T ;
Matsuo, H ;
Yada, T ;
Matsukura, S .
DIABETES, 2002, 51 (01) :124-129
[8]   Isoproterenol and somatostatin decrease plasma leptin in humans: A novel mechanism regulating leptin secretion [J].
Donahoo, WT ;
Jensen, DR ;
Yost, TJ ;
Eckel, RH .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (12) :4139-4143
[9]   Intracerebroventricular leptin increases lumbar and renal sympathetic nerve activity and blood pressure in normal rats [J].
Dunbar, JC ;
Hu, YG ;
Lu, HQ .
DIABETES, 1997, 46 (12) :2040-2043
[10]   Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues [J].
Guan, XM ;
Yu, H ;
Palyha, OC ;
McKee, KK ;
Feighner, SD ;
Sirinathsinghji, DJS ;
Smith, RG ;
VanderPloeg, LHT ;
Howard, AD .
MOLECULAR BRAIN RESEARCH, 1997, 48 (01) :23-29